Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations
(Q39966990)
scientific article
scientific article
Language:
Current Data About
Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations
| (P31) |
(Q13442814)
|
||||||||||||||||||||||||
| (P304) |
197-206
|
||||||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||||||
| (P433) |
2
|
||||||||||||||||||||||||
| (P478) |
415
|
||||||||||||||||||||||||
| (P577) |
Wednesday, October 1, 2008
|
||||||||||||||||||||||||
| (P1104) |
10
|
||||||||||||||||||||||||
| (P1433) |
(Q864221)
|
||||||||||||||||||||||||
| (P1476) |
"Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations" (language: en)
|
||||||||||||||||||||||||
| (P2093) |
Egle Avizienyte
Richard A Ward
Andrew P Garner
|
other details